Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy
Science Immunology · 28.02.2025 · 10 (104)
DOI: 10.1126/sciimmunol.adq4973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 28.02.2025. Verfasst von Vadim A Klenchin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. Hauptthemen laut MEDLINE: Simian Immunodeficiency Virus, Dependovirus, Simian Acquired Immunodeficiency Syndrome, Antibodies, Viral. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
An alternative to lifelong antiretroviral therapy (ART) is needed to achieve durable control of HIV-1. Here, we show that adeno-associated virus (AAV) delivery of two rhesus macaque antibodies to the simian immunodeficiency virus (SIV) envelope glycoprotein (Env) with potent neutralization and antibody-dependent cellular cytotoxicity can prevent viral rebound in macaques infected with barcoded SIV mac 239M after discontinuing suppressive ART. After AAV administration, sustained antibody expression with minimal antidrug antibody responses was achieved in all but one animal. After ART withdrawal, SIV replication rebounded within 2 weeks in all control animals but remained
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605, USA.
- Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53705, USA.
- AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
ORCID-Profile: Vadim A Klenchin, Natasha M Clark, Saverio Capuano, Rosemarie Mason, Guangping Gao, Aimee Broman, Taina T Immonen, Christine M Fennessey, Brandon F Keele, Jeffrey D Lifson, Mario Roederer, Matthew R Gardner, David T Evans
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Klenchin, V. A., Clark, N. M., Keles, N. K., Capuano, S., Mason, R., Gao, G., Broman, A., Kose, E., Immonen, T. T., Fennessey, C. M., Keele, B. F., Lifson, J. D., Roederer, M., Gardner, M. R., & Evans, D. T. (2025). Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy. Science Immunology, 10(104). https://doi.org/10.1126/sciimmunol.adq4973
Vancouver
Klenchin VA, Clark NM, Keles NK, Capuano S, Mason R, Gao G, et al. Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy. Science Immunology. 2025;10(104). doi:10.1126/sciimmunol.adq4973
BibTeX
@article{Klenchin2025,
author = {Klenchin, Vadim A and Clark, Natasha M and Keles, Nida K and Capuano, Saverio and Mason, Rosemarie and Gao, Guangping and Broman, Aimee and Kose, Emek and Immonen, Taina T and Fennessey, Christine M and Keele, Brandon F and Lifson, Jeffrey D and Roederer, Mario and Gardner, Matthew R and Evans, David T},
title = {Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {104},
doi = {10.1126/sciimmunol.adq4973}
}
EUVIMED